Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone

Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study

(2012) Jung Goo Lee et al.   Psychiatry Investigation

Hierarchical structure of the cognitive processes in schizophrenia: the fundamental role of processing speed

(2012) N. Ojeda et al.   SCHIZOPHRENIA RESEARCH

Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients

(2011) Norio Yasui-Furukori et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial

(2011) Joo-Cheol Shim et al.   NEUROPSYCHOPHARMACOLOGY

Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone

(2010) M. Riedel et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Dose-Dependent Effects of Adjunctive Treatment With Aripiprazole on Hyperprolactinemia Induced by Risperidone in Female Patients With Schizophrenia

(2010) Norio Yasui-Furukori et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Effect of Aripiprazole on Cognition in the Treatment of Patients with Schizophrenia

(2010) M. Riedel et al.   PHARMACOPSYCHIATRY

Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics

(2010) Chih-Ken Chen et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia

(2010) Hidenobu Suzuki et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder

(2010) K. E. Lewandowski et al.   PSYCHOLOGICAL MEDICINE

Effectiveness of Switching to Aripiprazole From Atypical Antipsychotics in Patients With Schizophrenia

(2009) Sung-Wan Kim et al.   CLINICAL NEUROPHARMACOLOGY

Aripiprazole

(2009) Shubhra Mace et al.   CNS DRUGS

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Adjunctive Aripiprazole for Schizophrenia or Schizoaffective Disorder Inadequately Treated With Quetiapine or Risperidone Monotherapy

(2009) John M. Kane et al.   JOURNAL OF CLINICAL PSYCHIATRY

Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study

(2009) Jun Soo Kwon et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Metabolism of Atypical Antipsychotics: Involvement of Cytochrome P450 Enzymes and Relevance for Drug-Drug Interactions

(2008) Liana Urichuk et al.   CURRENT DRUG METABOLISM

Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors

(2008) Yoshihiro Tadori et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Antipsychotic-Induced Hyperprolactinemia

(2008) Jolene R Bostwick et al.   PHARMACOTHERAPY

Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: Analysis of a randomized, open-label study

(2008) Matthew J. Byerly et al.   SCHIZOPHRENIA RESEARCH